NO20084614L - Perkutanose absorpsjonspreparater omfattende antidemensmedikamenter - Google Patents
Perkutanose absorpsjonspreparater omfattende antidemensmedikamenterInfo
- Publication number
- NO20084614L NO20084614L NO20084614A NO20084614A NO20084614L NO 20084614 L NO20084614 L NO 20084614L NO 20084614 A NO20084614 A NO 20084614A NO 20084614 A NO20084614 A NO 20084614A NO 20084614 L NO20084614 L NO 20084614L
- Authority
- NO
- Norway
- Prior art keywords
- drug
- percutaneous absorption
- skin
- antidepressant
- antidepressant drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Det beskrives et perkutant absorpsjonspreparat som muliggjør stabil administrering av et antidemenslegemiddel i et lengre tidsrom. Nærmere bestemt omfatter det perkutane absorpsjonspreparat av antidemenslegemiddelet som anvendes som et plaster på hud i det minste et klebelag, en mellomliggende membran og et legemiddelreservoarlag i rekkefølge fra den side som er plastret på huden. Legemiddelreservoarlaget omfatter i det minste et antidemenslegemiddel, en aminert polymer, en polyol og én eller flere karboksylsyreestere. Den mellomliggende membran muliggjør kontrollert gjennomtrengning av antidemenslegemiddelet inn i siden av huden, klebelaget muliggjør plastringen av det perkutane absorpsjonspreparat på hud og er gjennomtrengelig for antidemenslegemiddelet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79829606P | 2006-05-08 | 2006-05-08 | |
PCT/JP2006/325813 WO2007129427A1 (ja) | 2006-05-08 | 2006-12-25 | 抗認知症薬物の経皮吸収製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20084614L true NO20084614L (no) | 2009-02-06 |
Family
ID=38667540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084614A NO20084614L (no) | 2006-05-08 | 2008-10-31 | Perkutanose absorpsjonspreparater omfattende antidemensmedikamenter |
Country Status (17)
Country | Link |
---|---|
US (2) | US7858114B2 (no) |
EP (1) | EP2016939B1 (no) |
JP (1) | JP5122445B2 (no) |
KR (1) | KR20090009951A (no) |
CN (1) | CN101460156B (no) |
AU (1) | AU2006343077B2 (no) |
BR (1) | BRPI0621655A2 (no) |
CA (1) | CA2651596C (no) |
ES (1) | ES2466647T3 (no) |
HK (1) | HK1130175A1 (no) |
IL (1) | IL195174A0 (no) |
IN (1) | IN266817B (no) |
MY (1) | MY149152A (no) |
NO (1) | NO20084614L (no) |
NZ (1) | NZ572809A (no) |
RU (1) | RU2428179C2 (no) |
WO (1) | WO2007129427A1 (no) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080131491A1 (en) * | 2006-12-01 | 2008-06-05 | Akinori Hanatani | Percutaneously absorbable preparation |
BRPI0719307A2 (pt) * | 2006-12-01 | 2014-02-04 | Nitto Denko Corp | Método para a supressão da descoloração ao longo do tempo da preparação adesiva contendo donepezil. |
EP2269593B1 (en) * | 2008-03-25 | 2018-05-02 | Teikoku Seiyaku Co., Ltd. | Transdermally absorbable preparation |
US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
BRPI0913229A2 (pt) * | 2008-05-30 | 2016-01-19 | Nitto Denko Corp | preparação adesiva contendo donepezil e embalagem da mesma |
KR20110020788A (ko) * | 2008-05-30 | 2011-03-03 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 경피 흡수 제제 |
JP2012504163A (ja) * | 2008-09-30 | 2012-02-16 | テイコク ファーマ ユーエスエー インコーポレーテッド | 経皮持続送達ドネペジル組成物および該組成物を使用する方法 |
US20100278895A1 (en) | 2009-04-30 | 2010-11-04 | Medtronic, Inc. | Antioxidants and antimicrobial accessories including antioxidants |
WO2011034323A2 (en) | 2009-09-16 | 2011-03-24 | Samyang Corporation | Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system |
WO2011074637A1 (ja) | 2009-12-16 | 2011-06-23 | 後藤 武 | 抗認知症薬物の経皮吸収製剤 |
JP2012236773A (ja) * | 2009-12-16 | 2012-12-06 | Goto Takeshi | 抗認知症薬物の経皮吸収製剤 |
US20120282303A1 (en) * | 2009-12-16 | 2012-11-08 | Takeshi Ito | Percutaneous absorption preparation comprising anti-dementia drug |
WO2011076621A2 (de) * | 2009-12-22 | 2011-06-30 | Acino Ag | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten |
US10076502B2 (en) | 2009-12-22 | 2018-09-18 | Luye Pharma Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
NZ605352A (en) * | 2010-06-30 | 2013-10-25 | Nal Pharmaceuticals Ltd | Process for producing glycosaminoglycans |
SI2468274T1 (sl) * | 2010-12-14 | 2015-10-30 | Acino Ag | Transdermalni terapevtski sistem za dajanje aktivne snovi |
US8911427B2 (en) * | 2010-12-28 | 2014-12-16 | Medtronic, Inc. | Therapeutic agent reservoir delivery system |
TWI433904B (zh) * | 2011-01-12 | 2014-04-11 | Taiwan Biotech Co Ltd | 多奈哌齊經皮貼片 |
KR101054317B1 (ko) | 2011-01-28 | 2011-08-08 | 신신제약 주식회사 | 리바스티그민을 함유하는 경피흡수제제 |
KR101317158B1 (ko) | 2011-02-18 | 2013-10-15 | 조선대학교산학협력단 | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
JP6017543B2 (ja) | 2011-05-20 | 2016-11-02 | エスケー ケミカルズ カンパニー, リミテッドSk Chemicals Co., Ltd. | リバスティグミン含有パッチ |
KR101395557B1 (ko) * | 2011-08-25 | 2014-05-16 | 아이큐어 주식회사 | 경피 흡수 제제 및 그 제조방법 |
KR101239150B1 (ko) * | 2012-02-28 | 2013-03-06 | 에스케이케미칼주식회사 | 도네페질-함유 경피흡수제제 및 그의 제조방법 |
KR101964295B1 (ko) * | 2012-09-05 | 2019-04-01 | 주식회사 한독 | 피부 자극이 감소된 메만틴 경피전달 시스템 |
UA114016C2 (xx) * | 2012-12-13 | 2017-04-10 | Композиції, що містять вортіоксетин та донепезил | |
JP6151935B2 (ja) * | 2013-03-11 | 2017-06-21 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
WO2015127280A1 (en) | 2014-02-20 | 2015-08-27 | Nal Pharmaceuticals, Ltd. | Transdermal drug delivery system containing donepezil |
CN115252586A (zh) | 2015-06-22 | 2022-11-01 | 考里安公司 | 包含难溶性治疗剂的透皮粘合剂组合物 |
CN107530278A (zh) | 2015-06-29 | 2018-01-02 | 积水化学工业株式会社 | 芯壳结构体及外用剂 |
CA3028436A1 (en) | 2016-06-23 | 2017-12-28 | Corium International, Inc. | Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent |
AU2017302305A1 (en) | 2016-07-27 | 2019-02-14 | Corium, LLC. | Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery |
CN109789113A (zh) * | 2016-07-27 | 2019-05-21 | 考里安国际公司 | 美金刚透皮递送系统 |
AU2017301928B2 (en) | 2016-07-27 | 2023-04-06 | Corium, LLC. | Donepezil transdermal delivery system |
CN110234325A (zh) * | 2017-02-28 | 2019-09-13 | 金伯利-克拉克环球有限公司 | 用于维护微生物群落的健康平衡的协同组合物 |
CN108096690B (zh) * | 2017-04-07 | 2019-08-20 | 杭州多泰科技有限公司 | 一种诱导循环肿瘤细胞转移的可移植支架的制备方法 |
KR102033686B1 (ko) | 2017-05-19 | 2019-10-18 | 보령제약 주식회사 | 도네페질을 함유하는 마이크로니들 경피 패치 |
EP3658127A1 (en) * | 2017-07-26 | 2020-06-03 | Corium, Inc. | Transdermal delivery system with a microporous membrane having solvent-filled pores |
WO2019118782A1 (en) | 2017-12-13 | 2019-06-20 | Corium, Inc. | Method for depot creation during transdermal drug delivery |
WO2019126531A1 (en) | 2017-12-20 | 2019-06-27 | Corium, Inc. | Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point |
CN108926549A (zh) * | 2018-09-27 | 2018-12-04 | 安徽安科余良卿药业有限公司 | 卡巴拉汀凝胶贴膏及其制备方法 |
CN117500923A (zh) | 2021-04-07 | 2024-02-02 | 巴特尔纪念研究院 | 用于鉴定和使用非病毒载体的快速设计、构建、测试和学习技术 |
KR102489860B1 (ko) * | 2021-09-02 | 2023-01-19 | 동아에스티 주식회사 | 메만틴 에난트산염을 포함하는 치매 치료용 경피흡수 제제 |
CN115957200A (zh) * | 2023-02-23 | 2023-04-14 | 广州新济药业科技有限公司 | 一种美金刚透皮贴剂及制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991003998A1 (en) | 1989-09-14 | 1991-04-04 | Cygnus Research Corporation | Transdermal delivery device having delayed onset |
JP2977254B2 (ja) | 1990-09-04 | 1999-11-15 | 積水化学工業株式会社 | 経皮吸収貼付剤 |
US5273756A (en) | 1991-08-23 | 1993-12-28 | Cygnus Therapeutic Systems | Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset |
JPH06199659A (ja) * | 1992-10-28 | 1994-07-19 | Hisamitsu Pharmaceut Co Inc | 経皮治療用装置 |
AU7396294A (en) * | 1993-06-25 | 1995-01-24 | Alza Corporation | Incorporating poly-n-vinyl amide in a transdermal system |
US5635203A (en) * | 1994-09-29 | 1997-06-03 | Alza Corporation | Transdermal device having decreased delamination |
DE19533772C1 (de) * | 1995-09-12 | 1998-01-02 | Hexal Ag | Tacrin/Selegilin-Pflaster |
DE19653605C2 (de) * | 1996-12-20 | 2002-11-28 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems |
JPH10315016A (ja) | 1997-05-15 | 1998-12-02 | Nissan Diesel Motor Co Ltd | チャック装置 |
JP3987655B2 (ja) | 1998-03-03 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬を含有した経皮適用製剤又は坐剤 |
GB9917290D0 (en) * | 1999-07-22 | 1999-09-22 | Glaxo Wellcome Spa | Pharmaceutical composition |
DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
FR2814368B1 (fr) * | 2000-09-26 | 2004-05-07 | Pf Medicament | Preparation pharmaceutique a base d'oxans |
WO2002038139A1 (fr) * | 2000-11-07 | 2002-05-16 | Hisamitsu Pharmaceutical Co., Inc. | Preparation pharmaceutique du type a absorption percutanee |
DE10060550C1 (de) * | 2000-12-06 | 2002-04-18 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten |
US20040258741A1 (en) * | 2001-10-17 | 2004-12-23 | Takaaki Terahara | Percutaneous absorption preparations |
DE10220230A1 (de) * | 2002-05-06 | 2003-11-27 | Sanol Arznei Schwarz Gmbh | Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms |
JP4274951B2 (ja) * | 2004-01-07 | 2009-06-10 | 久光製薬株式会社 | 異型断面繊維を使用した支持体を有するテーピング型貼付剤 |
US20080038328A1 (en) * | 2004-05-28 | 2008-02-14 | Naruhito Higo | Pasting Preparation |
-
2006
- 2006-12-25 CN CN200680054495XA patent/CN101460156B/zh active Active
- 2006-12-25 IN IN2543MUN2008 patent/IN266817B/en unknown
- 2006-12-25 MY MYPI20084469A patent/MY149152A/en unknown
- 2006-12-25 ES ES06835183.2T patent/ES2466647T3/es active Active
- 2006-12-25 EP EP06835183.2A patent/EP2016939B1/en active Active
- 2006-12-25 NZ NZ572809A patent/NZ572809A/en not_active IP Right Cessation
- 2006-12-25 JP JP2008514366A patent/JP5122445B2/ja active Active
- 2006-12-25 KR KR1020087029711A patent/KR20090009951A/ko not_active Application Discontinuation
- 2006-12-25 CA CA2651596A patent/CA2651596C/en active Active
- 2006-12-25 WO PCT/JP2006/325813 patent/WO2007129427A1/ja active Application Filing
- 2006-12-25 BR BRPI0621655-2A patent/BRPI0621655A2/pt not_active IP Right Cessation
- 2006-12-25 RU RU2008148131/15A patent/RU2428179C2/ru not_active IP Right Cessation
- 2006-12-25 AU AU2006343077A patent/AU2006343077B2/en active Active
-
2007
- 2007-05-07 US US11/797,722 patent/US7858114B2/en not_active Expired - Fee Related
-
2008
- 2008-10-31 NO NO20084614A patent/NO20084614L/no not_active Application Discontinuation
- 2008-11-09 IL IL195174A patent/IL195174A0/en unknown
-
2009
- 2009-09-04 HK HK09108096.7A patent/HK1130175A1/xx not_active IP Right Cessation
-
2010
- 2010-11-17 US US12/948,252 patent/US20110059141A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2006343077B2 (en) | 2012-11-08 |
RU2008148131A (ru) | 2010-06-20 |
CN101460156A (zh) | 2009-06-17 |
EP2016939A4 (en) | 2013-01-09 |
CA2651596A1 (en) | 2007-11-15 |
JP5122445B2 (ja) | 2013-01-16 |
NZ572809A (en) | 2011-02-25 |
BRPI0621655A2 (pt) | 2011-12-20 |
JPWO2007129427A1 (ja) | 2009-09-17 |
IN266817B (no) | 2015-06-03 |
EP2016939A1 (en) | 2009-01-21 |
CN101460156B (zh) | 2011-06-08 |
WO2007129427A1 (ja) | 2007-11-15 |
ES2466647T3 (es) | 2014-06-10 |
US20070259028A1 (en) | 2007-11-08 |
EP2016939B1 (en) | 2014-03-19 |
IL195174A0 (en) | 2009-08-03 |
MY149152A (en) | 2013-07-15 |
HK1130175A1 (en) | 2009-12-24 |
US7858114B2 (en) | 2010-12-28 |
US20110059141A1 (en) | 2011-03-10 |
RU2428179C2 (ru) | 2011-09-10 |
KR20090009951A (ko) | 2009-01-23 |
CA2651596C (en) | 2014-03-25 |
AU2006343077A1 (en) | 2007-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20084614L (no) | Perkutanose absorpsjonspreparater omfattende antidemensmedikamenter | |
EA201000747A1 (ru) | Система и способ трансдермальной доставки и способ получения системы трансдермальной доставки | |
DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
WO2008100576A3 (en) | Sustained delivery formulations of rapamycin compounds | |
TW200642700A (en) | Chemically defined stabiliser | |
AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
ITMI20041820A1 (it) | Composizione in micro-pellets a rilascio controllato di sostanze fisiologicamente attive, procedimento di preparazione e relativo impiego nel settore zootecnico. | |
MX2011006527A (es) | Agentes medicinales unidos a dipeptido. | |
NO20092998L (no) | Flytende formuleringer, som danner dermal film, for frigjoring av legemidler til huden | |
NZ591261A (en) | Improvements in the absorption of therapeutic agents across mucosal membranes or the skin | |
BRPI0707235B8 (pt) | formulação de fentanil sublingual sem propelente, e, dispositivo de dose unitária para administração sublingual de uma formulação de fentanil sublingual | |
AR069552A1 (es) | Formulaciones para el tratamiento de semillas y metodos de uso | |
AR060755A1 (es) | Formulaciones de inhibidores de dipeptidil peptidasa iv (dpp iv) | |
ATE410424T1 (de) | Spirocyclische cyclohexan-derivate | |
NO20074811L (no) | Utvendig plaster inneholdende flurbiprofen | |
BR112012017168A2 (pt) | sistema terapêutico transdérmico para administração de rivastigmina ou seus derivados | |
NZ611920A (en) | Percutaneous absorption preparation containing rivastigmine | |
CY1116638T1 (el) | Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας | |
DK1962815T3 (da) | Anvendelse af filmdannende hårplejepolymerer fra gruppen polyurethaner og farmaceutiske tilberedninger og plastre indeholdende nævnte polymerer | |
BR112012003283A8 (pt) | sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, composição farmacêutica, produto, kit, uso de um sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, e, método de introdução de uma molécula de medicamento no citosol de uma célula em um paciente. | |
WO2006072329A3 (de) | Transdermales therapeutisches system mit aktivierbarer übersättigung und kontrollierter permeationsförderung | |
DE60231862D1 (de) | Erodierbare polymere zur injektion | |
CL2004000566A1 (es) | Sistema de liberacion controlada que contiene un componente farmaceuticamente activo, acetato de isobutirato de sacarosa (saib), y como disolvente glicerolformal o isopropilidenglicerol o una mezcla de los mismos. | |
PH12017501527A1 (en) | Oral hemostatic and wound-protective film | |
DK1749517T3 (da) | Stabil farmaceutiske sammensætning af linezolid form IV |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |